The story of Sildenafil presents a interesting case for stakeholders in the pharmaceutical sector. While initially a phenomenal success, generating huge profits, the intellectual property expiration and the subsequent https://adult545798.nizarblog.com/42116940/sildenafil-and-pharma-a-risky-investment